143 related articles for article (PubMed ID: 22332993)
1. Protective effects of lactoferrin chimera and bovine lactoferrin in a mouse model of enterohaemorrhagic Escherichia coli O157:H7 infection.
Flores-Villaseñor H; Canizalez-Román A; Velazquez-Roman J; Nazmi K; Bolscher JG; Leon-Sicairos N
Biochem Cell Biol; 2012 Jun; 90(3):405-11. PubMed ID: 22332993
[TBL] [Abstract][Full Text] [Related]
2. Lactoferrin increases both resistance to Salmonella typhimurium infection and the production of antibodies in mice.
Drago-Serrano ME; Rivera-Aguilar V; Reséndiz-Albor AA; Campos-Rodríguez R
Immunol Lett; 2010 Nov; 134(1):35-46. PubMed ID: 20727369
[TBL] [Abstract][Full Text] [Related]
3. Lactoferrin stimulates killing and clearance of bacteria but does not prevent mortality of diabetic mice.
Zagulski T; Jarzabek Z; Zagulska A; Jaszczak M; Kochanowska IE; Zimecki M
Arch Immunol Ther Exp (Warsz); 2001; 49(6):431-8. PubMed ID: 11814237
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial and immunomodulatory activities of bovine lactoferrin against Escherichia coli O157:H7 infections in cattle.
Kieckens E; Rybarczyk J; Cox E; Vanrompay D
Biometals; 2018 Jun; 31(3):321-330. PubMed ID: 29442205
[TBL] [Abstract][Full Text] [Related]
5. Clearance of Escherichia coli O157:H7 infection in calves by rectal administration of bovine lactoferrin.
Kieckens E; Rybarczyk J; De Zutter L; Duchateau L; Vanrompay D; Cox E
Appl Environ Microbiol; 2015 Mar; 81(5):1644-51. PubMed ID: 25527551
[TBL] [Abstract][Full Text] [Related]
6. Cathelicidin- derived PR39 protects enterohemorrhagic Escherichia coli O157:H7 challenged mice by improving epithelial function and balancing the microbiota in the intestine.
Haiwen Z; Rui H; Bingxi Z; Qingfeng G; Beibei W; Jifeng Z; Xuemei W; Kebang W
Sci Rep; 2019 Jul; 9(1):9456. PubMed ID: 31263234
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of bovine lactoferrin and its peptides against enterohaemorrhagic Escherichia coli O157:H7.
Shin K; Yamauchi K; Teraguchi S; Hayasawa H; Tomita M; Otsuka Y; Yamazaki S
Lett Appl Microbiol; 1998 Jun; 26(6):407-11. PubMed ID: 9717310
[TBL] [Abstract][Full Text] [Related]
8. Effect of lactoferrin on release and bioactivity of Shiga toxins from different Escherichia coli O157:H7 strains.
Kieckens E; Rybarczyk J; Barth SA; Menge C; Cox E; Vanrompay D
Vet Microbiol; 2017 Apr; 202():29-37. PubMed ID: 27039884
[TBL] [Abstract][Full Text] [Related]
9. Effects on Escherichia coli O157:H7 and meat starter cultures of bovine lactoferrin in broth and microencapsulated lactoferrin in dry sausage batters.
Al-Nabulsi AA; Holley RA
Int J Food Microbiol; 2007 Jan; 113(1):84-91. PubMed ID: 16996159
[TBL] [Abstract][Full Text] [Related]
10. Design and activity of novel lactoferrampin analogues against O157:H7 enterohemorrhagic Escherichia coli.
Cruz J; Ortiz C; Guzmán F; Cárdenas C; Fernandez-Lafuente R; Torres R
Biopolymers; 2014 Apr; 101(4):319-28. PubMed ID: 23877962
[TBL] [Abstract][Full Text] [Related]
11. B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: a novel peptide vaccine candidate.
Wan CS; Zhou Y; Yu Y; Peng LJ; Zhao W; Zheng XL
Microbiol Immunol; 2011 Apr; 55(4):247-53. PubMed ID: 21272063
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin and lactoferrin chimera inhibit damage caused by enteropathogenic Escherichia coli in HEp-2 cells.
Flores-Villaseñor H; Canizalez-Román A; de la Garza M; Nazmi K; Bolscher JG; Leon-Sicairos N
Biochimie; 2012 Sep; 94(9):1935-42. PubMed ID: 22640957
[TBL] [Abstract][Full Text] [Related]
13. Enhancing the antimicrobial effects of bovine lactoferrin against Escherichia coli O157:H7 by cation chelation, NaCl and temperature.
Al-Nabulsi AA; Holley RA
J Appl Microbiol; 2006 Feb; 100(2):244-55. PubMed ID: 16430500
[TBL] [Abstract][Full Text] [Related]
14. Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice.
Rahal EA; Kazzi N; Kanbar A; Abdelnoor AM; Matar GM
Int J Antimicrob Agents; 2011 Feb; 37(2):135-9. PubMed ID: 21129928
[TBL] [Abstract][Full Text] [Related]
15. Reduction of Escherichia coli O157:H7 excretion in sheep by oral lactoferrin administration.
Yekta MA; Cox E; Goddeeris BM; Vanrompay D
Vet Microbiol; 2011 Jun; 150(3-4):373-8. PubMed ID: 21511407
[TBL] [Abstract][Full Text] [Related]
16. The synergistic effect of nisin and lactoferrin on the inhibition of Listeria monocytogenes and Escherichia coli O157:H7.
Murdock CA; Cleveland J; Matthews KR; Chikindas ML
Lett Appl Microbiol; 2007 Mar; 44(3):255-61. PubMed ID: 17309501
[TBL] [Abstract][Full Text] [Related]
17. Use of immunoglobulin enriched bovine colostrum against oral challenge with enterohaemorrhagic Escherichia coli O157:H7 in mice.
Funatogawa K; Ide T; Kirikae F; Saruta K; Nakano M; Kirikae T
Microbiol Immunol; 2002; 46(11):761-6. PubMed ID: 12516772
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal effect of bovine lactoferrin and synthetic peptide lactoferrin chimera in Streptococcus pneumoniae and the decrease in luxS gene expression by lactoferrin.
León-Sicairos N; Angulo-Zamudio UA; Vidal JE; López-Torres CA; Bolscher JG; Nazmi K; Reyes-Cortes R; Reyes-López M; de la Garza M; Canizalez-Román A
Biometals; 2014 Oct; 27(5):969-80. PubMed ID: 25053107
[TBL] [Abstract][Full Text] [Related]
19. Reduced faecal shedding of Escherichia coli O157:H7 in cattle following systemic vaccination with γ-intimin C₂₈₀ and EspB proteins.
Vilte DA; Larzábal M; Garbaccio S; Gammella M; Rabinovitz BC; Elizondo AM; Cantet RJ; Delgado F; Meikle V; Cataldi A; Mercado EC
Vaccine; 2011 May; 29(23):3962-8. PubMed ID: 21477674
[TBL] [Abstract][Full Text] [Related]
20. Oral Administration of Bovine Lactoferrin-Derived Lactoferricin (Lfcin) B Could Attenuate Enterohemorrhagic Escherichia coli O157:H7 Induced Intestinal Disease through Improving Intestinal Barrier Function and Microbiota.
Haiwen Z; Rui H; Bingxi Z; Qingfeng G; Jifeng Z; Xuemei W; Beibei W
J Agric Food Chem; 2019 Apr; 67(14):3932-3945. PubMed ID: 30892034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
